hNPC-02

N/A

Report date: 2023/02/18 19:34:58

Base Information

Drug NamehNPC-02
Drug Alias NamehNPC-02
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord InjuriesAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Huode Bioengineering Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Huode Bioengineering Company Ltd
Inactive CompaniesN/A
Active IndicationsSpinal Cord InjuriesAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A